Literature DB >> 29366961

Inkjet printing of paracetamol and indomethacin using electromagnetic technology: Rheological compatibility and polymorphic selectivity.

Gayathri Kollamaram1, Simon C Hopkins2, Bartek A Glowacki3, Denise M Croker4, Gavin M Walker4.   

Abstract

Drop-on-demand inkjet printing is a potential enabling technology both for continuous manufacturing of pharmaceuticals and for personalized medicine, but its use is often restricted to low-viscosity solutions and nano-suspensions. In the present study, a robust electromagnetic (valvejet) inkjet technology has been successfully applied to deposit prototype dosage forms from solutions with a wide range of viscosities, and from suspensions with particle sizes exceeding 2 μm. A detailed solid-state study of paracetamol, printed from a solution ink on hydroxypropyl methylcellulose (HPMC), revealed that the morphology of the substrate and its chemical interactions can have a considerable influence on polymorphic selectivity. Paracetamol ink crystallized exclusively into form II when printed on a smooth polyethylene terephthalate substrate, and exclusively into form I when in sufficient proximity to the rough surface of the HPMC substrate to be influenced by confinement in pores and chemical interactions. The relative standard deviation in the strength of the dosage forms was <4% in all cases, for doses as low as 0.8 mg, demonstrating the accuracy and reproducibility associated with electromagnetic inkjet technology. Good adhesion of indomethacin on HPMC was achieved using a suspension ink with hydroxypropyl cellulose, but not on an alternative polyethylene terephthalate substrate, emphasising the need to tailor the binder to the substrate. Future work will focus on lower-dose drugs, for which dosing flexibility and fixed dose combinations are of particular interest.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Electromagnetic technology; Indomethacin; Inkjet printing; Paracetamol

Mesh:

Substances:

Year:  2018        PMID: 29366961     DOI: 10.1016/j.ejps.2018.01.036

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  6 in total

1.  Valvejet Technology for the Production of a Personalised Fixed Dose Combination of Ramipril and Glimepiride: an Investigative Study on the Stability of Ramipril.

Authors:  Gayathri Kollamaram; Alexandra Faucher; Denise M Croker; Gavin M Walker
Journal:  Pharm Res       Date:  2018-07-27       Impact factor: 4.200

Review 2.  Engineering approaches to studying cancer cell migration in three-dimensional environments.

Authors:  Noam Zuela-Sopilniak; Jan Lammerding
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-01       Impact factor: 6.237

3.  Crystallization of Form II Paracetamol with the Assistance of Carboxylic Acids toward Batch and Continuous Processes.

Authors:  Kuan-Lin Yeh; Hung-Lin Lee; Tu Lee
Journal:  Pharmaceutics       Date:  2022-05-20       Impact factor: 6.525

Review 4.  3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling.

Authors:  Xuanyi Ma; Justin Liu; Wei Zhu; Min Tang; Natalie Lawrence; Claire Yu; Maling Gou; Shaochen Chen
Journal:  Adv Drug Deliv Rev       Date:  2018-06-21       Impact factor: 15.470

5.  In Vitro Evaluation of 2D-Printed Edible Films for the Buccal Delivery of Diclofenac Sodium.

Authors:  Georgios K Eleftheriadis; Paraskevi Kyriaki Monou; Nikolaos Bouropoulos; Dimitrios G Fatouros
Journal:  Materials (Basel)       Date:  2018-05-22       Impact factor: 3.623

6.  A Pediatrics Utilization Study in The Netherlands to Identify Active Pharmaceutical Ingredients Suitable for Inkjet Printing on Orodispersible Films.

Authors:  J Carolina Visser; Lisa Wibier; Olga Kiefer; Mine Orlu; Jörg Breitkreutz; Herman J Woerdenbag; Katja Taxis
Journal:  Pharmaceutics       Date:  2020-02-17       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.